Informatics and Artificial Intelligence–Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022 Our approach used an ...
Neoadjuvant aromatase inhibitor therapy for ER+ breast cancer: The NAOMI trial. Long-term outcomes of neoadjuvant treatment in older patients with HER2-positive breast cancer: Evidence from a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback